Key result
TRIM5α utilizes multiple domains to recognize diverse viral molecular patterns beyond retroviruses.
Why the study?
Recent evidence showing TRIM5alpha restricts retroelements and distinct viral families raises questions regarding its genetic and structural plasticity in recognizing diverse viral patterns.
This review highlights the structural plasticity and evolutionary dynamics of TRIM5α in recognizing diverse viral molecular patterns.
Broadens TRIM5α antiviral scope beyond retroviruses; leaves open therapeutic targeting in diverse infections.
The evolutionary pressures exerted by viral infections have led to the development of various cellular proteins with potent antiviral activities, some of which are known as antiviral restriction factors. TRIpartite Motif-containing protein 5 alpha (TRIM5α) is a well-studied restriction factor of retroviruses that exhibits virus- and host-species-specific functions in protecting against cross-primate transmission of specific lentiviruses. This specificity is achieved at the level of the host gene through positive selection predominantly within its C-terminal B30.2/PRYSPRY domain, which is responsible for the highly specific recognition of retroviral capsids. However, more recent work has challenged this paradigm, demonstrating TRIM5α as a restriction factor for retroelements as well as phylogenetically distinct viral families, acting similarly through the recognition of viral gene products via B30.2/PRYSPRY. This spectrum of antiviral activity raises questions regarding the genetic and structural plasticity of this protein as a mediator of the recognition of a potentially diverse array of viral molecular patterns. This review highlights the dynamic evolutionary footprint of the B30.2/PRYSPRY domain in response to retroviruses while exploring the guided 'specificity' conferred by the totality of TRIM5α's additional domains that may account for its recently identified promiscuity.
No takes yet. Share an insight, caveat, or question.
Spada et al. (2024) conducted a review in Viral infections. TRIM5α was evaluated. TRIM5α functions as a versatile antiviral restriction factor, utilizing its B30.2/PRYSPRY and additional domains to recognize a diverse array of viral molecular patterns beyond retroviruses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: